Sulfamethoxazole (SMX) is an antibiotic of growing environmental concern. As specific filter material for the extraction of SMX from waters, a series of SMX-imprinted polymers have been synthesised varying their composition parameters, and their efficiency to selectively remove the contaminant SMX from complex polluted water was tested. Most of the developed materials exhibited an excellent uptake of the target pollutant SMX of more than 80% or even 90% and effective separation from selected easily degradable accompanying substances even in complex wastewater mixtures. All the results for SMX uptake and release were compared to the commonly used adsorbent activated carbon (AC).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jhazmat.2009.05.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug-induced renal tubular acidosis in a patient receiving trimethoprim-sulfamethoxazole.
BMJ Case Rep
January 2025
General Surgery, Changi General Hospital, Singapore.
An Asian woman in her 70s was started on trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of her left fourth toe osteomyelitis. During the course of her therapy, she developed renal tubular acidosis despite being immunocompetent with no known renal disease. Cessation of TMP-SMX and supportive care resulted in resolution of her condition.
View Article and Find Full Text PDFPharmaceuticals removal from aqueous solution by water hyacinth (Eichhornia crassipes): a comprehensive investigation of kinetics, equilibrium, and thermodynamics.
Environ Sci Pollut Res Int
January 2025
Grupo de Investigación Materiales Con Impacto (Mat&Mpac), Facultad de Ciencias Básicas, Universidad de Medellín, Carrera 87 No. 30-65, 050026, Medellín, Colombia.
This study shows the efficiency of WH-C450, an adsorbent obtained from water hyacinth (WH) biomass, in the removal of sulfamethoxazole (SMX) from aqueous solutions. The process involves calcination of WH at 450 °C to produce an optimal adsorbent material capable of removing up to 73% of SMX and maximum SMX adsorption capacity of 132.23 mg/g.
View Article and Find Full Text PDFRevealing the enhanced role of hydroxylamine and bimetals in the CuFeO/PMS/HA system towards effective degradation of organic contaminants.
J Hazard Mater
January 2025
Institute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", Agia Paraskevi, Athens 15310, Greece. Electronic address:
In this study, a hydroxylamine (HA)-enhanced magnetic spinel catalyst CuFeO-activated peroxymonosulfate (PMS) system (CuFeO/PMS/HA) was constructed to degrade Sulfamethoxazole (SMX). Results from experiments and theoretical calculations indicated that active species generation mechanism involved the direct activation of PMS by HA, the redox cycles acceleration on the surface of CuFeO by HA, and the synergistic action of the low valence Fe and Cu species in CuFeO for PMS activation. The efficacy of other organic pollutants removal was further validated in bio-treated landfill leachate through removal performance and toxicity assessment.
View Article and Find Full Text PDFEnhanced degradation of sulfamethoxazole in water by biochar loading and multiple free and non-free radicals cooperating in the FeS@BC/PS system.
J Environ Manage
January 2025
Institute of Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, PR China. Electronic address:
The excessive consumption of sulfamethoxazole (SMX), a pharmaceutical antibiotic, poses significant environmental hazards. The FeS-persulfate (FeS-PS) system has been employed for SMX remediation because of its excellent performance. However, FeS tends to agglomerate and become passivated, negatively impacting its activation performance.
View Article and Find Full Text PDFManagement and Outcome of Invasive Clindamycin-Resistant MRSA Community-Associated Infections in Children.
Antibiotics (Basel)
January 2025
Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Background: Clindamycin resistance among community-associated methicillin-resistant (CA-MRSA) complicates the management of a challenging infection. Little data exist to guide clinicians in the management of invasive clindamycin-resistant CA-MRSA infections in children and studies using oral regimens such as trimethoprim-sulfamethoxazole (TMP-SMX) and linezolid for treatment of these infections are limited. We sought to reevaluate antibiotic management among invasive CA-MRSA at a tertiary children's hospital.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!